Quick Overview: Join us for an insightful webinar exploring the emerging role of minimal residual disease ( Brian Durie, MD, Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, discusses measurable residual disease ( Tumor-informed liquid biopsy stands as the gold standard for monitoring
Ask The Expert Mrd Testing - Detailed Overview & Context
Join us for an insightful webinar exploring the emerging role of minimal residual disease ( Brian Durie, MD, Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, discusses measurable residual disease ( Tumor-informed liquid biopsy stands as the gold standard for monitoring Learn more about Minimal Residual Disease ( Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing role of circulating tumor DNA (ctDNA) as a validated ... William Wierda, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the use of commercialized ...
Watch the full course and our most up-to-date content here: Create a free account to track ... While not yet mainstream in the community setting, measurable residual disease ( Dr. Neha Korde, from Memorial Sloan Kettering Cancer Center, discussed Minimal Residual Disease ( Presented by Dr. Tony Sanchez and Josh Wemmer from Invivoscribe, Inc.
